These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36754343)

  • 1. Non-canonical inhibition strategies and structural basis of anti-CRISPR proteins targeting type I CRISPR-Cas systems.
    Yin P; Zhang Y; Yang L; Feng Y
    J Mol Biol; 2023 Apr; 435(7):167996. PubMed ID: 36754343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
    Liu Q; Zhang H; Huang X
    FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CRISPR Discovery: Using Magnets to Find Needles in Haystacks.
    Forsberg KJ
    J Mol Biol; 2023 Apr; 435(7):167952. PubMed ID: 36638909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems.
    Mohanraju P; Makarova KS; Zetsche B; Zhang F; Koonin EV; van der Oost J
    Science; 2016 Aug; 353(6299):aad5147. PubMed ID: 27493190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs.
    Trasanidou D; Gerós AS; Mohanraju P; Nieuwenweg AC; Nobrega FL; Staals RHJ
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecology and evolution of phages encoding anti-CRISPR proteins.
    Pons BJ; van Houte S; Westra ER; Chevallereau A
    J Mol Biol; 2023 Apr; 435(7):167974. PubMed ID: 36690071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type II anti-CRISPR proteins as a new tool for synthetic biology.
    Zhang Y; Marchisio MA
    RNA Biol; 2021 Aug; 18(8):1085-1098. PubMed ID: 32991234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.
    Borges AL; Davidson AR; Bondy-Denomy J
    Annu Rev Virol; 2017 Sep; 4(1):37-59. PubMed ID: 28749735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage-Encoded Anti-CRISPR Defenses.
    Stanley SY; Maxwell KL
    Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Approaches for Prediction of Anti-CRISPR Proteins.
    Makarova KS; Wolf YI; Koonin EV
    J Mol Biol; 2023 Apr; 435(7):168036. PubMed ID: 36868398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage Against the Machine: Discovery and Mechanism of Type V Anti-CRISPRs.
    Marino ND
    J Mol Biol; 2023 Apr; 435(7):168054. PubMed ID: 36934807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CRISPR-Cas systems by mobile genetic elements.
    Sontheimer EJ; Davidson AR
    Curr Opin Microbiol; 2017 Jun; 37():120-127. PubMed ID: 28668720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins.
    Yang L; Zhang Y; Yin P; Feng Y
    RNA Biol; 2021 Nov; 18(sup2):562-573. PubMed ID: 34606423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine-learning approach expands the repertoire of anti-CRISPR protein families.
    Gussow AB; Park AE; Borges AL; Shmakov SA; Makarova KS; Wolf YI; Bondy-Denomy J; Koonin EV
    Nat Commun; 2020 Jul; 11(1):3784. PubMed ID: 32728052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas in mobile genetic elements: counter-defence and beyond.
    Faure G; Shmakov SA; Yan WX; Cheng DR; Scott DA; Peters JE; Makarova KS; Koonin EV
    Nat Rev Microbiol; 2019 Aug; 17(8):513-525. PubMed ID: 31165781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral diversity threshold for adaptive immunity in prokaryotes.
    Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
    mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CRISPRs: Protein Inhibitors of CRISPR-Cas Systems.
    Davidson AR; Lu WT; Stanley SY; Wang J; Mejdani M; Trost CN; Hicks BT; Lee J; Sontheimer EJ
    Annu Rev Biochem; 2020 Jun; 89():309-332. PubMed ID: 32186918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type II Anti-CRISPR Proteins.
    Hwang S; Maxwell KL
    J Mol Biol; 2023 Apr; 435(7):168041. PubMed ID: 36893938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of molecular mechanisms used by anti-CRISPR proteins: the tip of an iceberg?
    Hardouin P; Goulet A
    Biochem Soc Trans; 2020 Apr; 48(2):507-516. PubMed ID: 32196554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.